rethinkMushrooms Search
Menu
Research citation

Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Cancer immunology, immunotherapy : CII, 64(2), 237-47

Citation

Wesa, Kathleen M; Cunningham-Rundles, Susanna; Klimek, Virginia M; Vertosick, Emily; Coleton, Marci I; Yeung, K Simon; Lin, Hong; Nimer, Stephen; Cassileth, Barrie R. (2015). Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.. Cancer immunology, immunotherapy : CII, 64(2), 237-47. https://doi.org/10.1007/s00262-014-1628-6